Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study
- PMID: 35973707
- PMCID: PMC9386219
- DOI: 10.1136/bmjopen-2021-057361
Inpatient palliative care use by patients with sickle cell disease: a retrospective cross-sectional study
Abstract
Objective: Sickle cell disease (SCD) is a highly morbid condition notable for recurrent hospitalisations due to vaso-occlusive crises and complications of end organ damage. Little is known about the use of inpatient palliative care services in adult patients with SCD. This study aims to evaluate inpatient palliative care use during SCD-related hospitalisations overall and during terminal hospitalisations. We hypothesise that use of palliative care is low in SCD hospitalisations.
Design: A retrospective cross-sectional study using data from the National Inpatient Sample from 2008 to 2017 was conducted.
Setting: US hospitals from 47 states and the District of Columbia.
Participants: Patients >18 years old hospitalised with a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) or ICD-10-CM diagnosis of SCD were included.
Primary and secondary outcome measures: Palliative care service use (documented by ICD-9-CM and ICD-10-CM diagnosis codes V66.7 and Z51.5).
Results: 987 555 SCD-related hospitalisations were identified, of which 4442 (0.45%) received palliative care service. Palliative care service use increased at a rate of 9.2% per year (95% CI 5.6 to 12.9). NH-black and Hispanic patients were 33% and 53% less likely to have palliative care services compared with NH-white patients (OR 0.67; 95% CI 0.45 to 0.99 and OR 0.47; 95% CI 0.26 to 0.84). Female patients (OR 0.40; 95% CI 0.21 to 0.76), Medicaid use (OR 0.40; 95% CI 0.21 to 0.78), rural (OR 0.47; 95% CI 0.28 to 0.79) and urban non-teaching hospitals (OR 0.61; 95% CI 0.47 to 0.80) each had a lower likelihood of palliative care services use.
Conclusion: Use of palliative care during SCD-related hospitalisations is increasing but remains low. Disparities associated with race and gender exist for use of palliative care services during SCD-related hospitalisation. Further studies are needed to guide evidence-based palliative care interventions for more comprehensive and equitable care of adult patients with SCD.
Keywords: adult palliative care; anaemia; haematology.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Association of Sickle Cell Disease With Racial Disparities and Severe Maternal Morbidities in Black Individuals.JAMA Pediatr. 2023 Aug 1;177(8):808-817. doi: 10.1001/jamapediatrics.2023.1580. JAMA Pediatr. 2023. PMID: 37273202 Free PMC article.
-
Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States.Adv Ther. 2023 Aug;40(8):3543-3558. doi: 10.1007/s12325-023-02545-7. Epub 2023 Jun 18. Adv Ther. 2023. PMID: 37332020 Free PMC article.
-
Severe Maternal Morbidity and Mortality in Sickle Cell Disease in the National Inpatient Sample, 2012-2018.JAMA Netw Open. 2023 Feb 1;6(2):e2254552. doi: 10.1001/jamanetworkopen.2022.54552. JAMA Netw Open. 2023. PMID: 36729452 Free PMC article.
-
Standardization of coding definitions for sickle cell disease complications: A systematic literature review.Pharmacoepidemiol Drug Saf. 2024 Sep;33(9):e5769. doi: 10.1002/pds.5769. Pharmacoepidemiol Drug Saf. 2024. PMID: 39205482
-
End-of-life care for people with sickle cell disease: barriers to and facilitators of high-quality care.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):355-362. doi: 10.1182/hematology.2024000561. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644013 Free PMC article. Review.
Cited by
-
Disparities in Palliative Care Among Critically Ill Patients With and Without COVID-19 at the End of Life: A Population-Based Analysis.J Clin Med Res. 2023 Dec;15(10-11):438-445. doi: 10.14740/jocmr5027. Epub 2023 Dec 9. J Clin Med Res. 2023. PMID: 38189035 Free PMC article.
-
Naming racism as a root cause of inequities in palliative care research: a scoping review.BMC Palliat Care. 2024 Jun 10;23(1):143. doi: 10.1186/s12904-024-01465-9. BMC Palliat Care. 2024. PMID: 38858646 Free PMC article.
-
Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG).Genet Med Open. 2024 Sep 10;2:101875. doi: 10.1016/j.gimo.2024.101875. eCollection 2024. Genet Med Open. 2024. PMID: 39822266 Free PMC article. No abstract available.
-
Beyond IV push: alternative methods for management of acute pain in SCD.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):611-617. doi: 10.1182/hematology.2024000585. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644010 Free PMC article. Review.
-
A Study of the Clinical Profile of Iron Deficiency Anemia in Children With Sickle Cell Disease in a Tertiary Care Center.Cureus. 2024 Sep 24;16(9):e70087. doi: 10.7759/cureus.70087. eCollection 2024 Sep. Cureus. 2024. PMID: 39449937 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical